DGAP-News

Carl Zeiss Meditec AG: Carl Zeiss Meditec AG grows in Ophthalmology and Microsurgery - Seite 2

South America.


The APAC region generated revenue of EUR 278.7 million which is
significantly higher than the year-ago figure of EUR 231.6 million - an
increase by 20.3 percent. Adjusted for slight currency effects, growth
would still have been 17.1 percent. The lion's share of the increase came
from the Chinese market as well as from Southeast Asia and South Korea; the
Japanese market exhibited a sideways trend.

Dr. Ludwin Monz, CEO of Carl Zeiss Meditec AG, believes the Company is on
the right track and - in view of the 9-month figures - confirmed the
forecast for the current fiscal year with an annual revenue in the range of
EUR 1,080 - 1,120 million. "The result of the first three quarters endorses
our growth strategy. In particular the innovations launched recently
supported us to expand our market position, especially in Asia." In view of
the recently announced consolidation to focus the organizational structure
on the two core markets of the company, microsurgery and ophthalmology, he
said: "We want to improve service for our customers and tap into potentials
in various regional markets."

Revenue by strategic business unit

Figures in EUR k 9 Months 9 Months Change Change from
2014/15 2015/16 compared to previous year
prior year (adjusted for
currency
effects)
Ophthalmic 283,542 304,945 + 7.5% + 5.0%
Systems
Surgical 258,506 280,813 +8.6% + 7.1%
Ophthalmology
Microsurgery 206,653 212,838 + 3.0% + 0.6%



Revenue by region


Figures in 9 Months 9 Months Change Change from
EUR k 2014/15 2015/16 compared to previous year
prior year (adjusted for
currency
effects)
EMEA 261,932 262,516 + 0.2% + 0.6%
Americas 255,153 257,344 +0.9% -2.9%
APAC 231,616 278,736 + 20.3% 17.1%


Press contact:
Jann Gerrit Ohlendorf
Director Corporate Communications Carl Zeiss Meditec AG Phone [phone]
Email: [e-mail]

Investors contact:
Sebastian Frericks
Director Investor Relations Carl Zeiss Meditec AG Phone [phone]
Email: [e-mail]

www.zeiss.com/presse

Brief profile

Carl Zeiss Meditec AG (ISIN: DE 0005313704), which is listed on TecDAX of
the German stock exchange, is one of the world's leading medical technology
companies. The Company supplies innovative technologies and application-
oriented solutions designed to help doctors improve the quality of life of
their patients. It provides complete packages of solutions for the
diagnosis and treatment of eye diseases, including implants and consumable
materials. The company supplies innovative visualization solutions in the
field of microsurgery. Carl Zeiss Meditec AG's medical technology portfolio